Physician profile
Maya Green
NPI 1891952818
$8,148.38
in general payments reported to CMS, 2019-2025
10 companies · $671 in 2025
The $671 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $354 · 2021: $96.58 · 2022: $245 · 2023: $609 · 2024: $5,395 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,200 · Food and Beverage: $1,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,200.00 |
| Food and Beverage | $1,475.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $6,420.24 | 2019-2025 | Cabenuva, Apretude, Dovato |
| Gilead Sciences, INC. | $714.14 | 2019-2025 | Yeztugo |
| Janssen Scientific Affairs, LLC | $222.49 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $194.46 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Janssen Biotech, INC. | $165.44 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $145.70 | 2025 | Invega Trinza |
| Abbvie INC. | $142.62 | 2019-2025 | |
| Napo Pharmaceuticals INC | $96.05 | 2019-2023 | Mytesi |
| Dynavax Technologies Corporation | $24.38 | 2021 | |
| Emd Serono, INC. | $22.86 | 2023 | Serostim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maya Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.